当前位置: X-MOL 学术Aliment. Pharm. Ther. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Editorial: evolution of GLP-1 receptor agonists as pharmacotherapy for NASH beyond diabetes mellitus and obesity
Alimentary Pharmacology & Therapeutics ( IF 6.6 ) Pub Date : 2021-11-06 , DOI: 10.1111/apt.16641
Won Kim 1
Affiliation  

This article is linked to Flint et al papers. To view these articles, visit https://doi.org/10.1111/apt.16608 and https://doi.org/10.1111/apt.16669

中文翻译:

社论:GLP-1 受体激动剂作为糖尿病和肥胖以外 NASH 药物疗法的演变

本文链接到 Flint 等人的论文。要查看这些文章,请访问 https://doi.org/10.1111/apt.16608 和 https://doi.org/10.1111/apt.16669
更新日期:2021-11-07
down
wechat
bug